Keywords: va, study, rates, hytrin, over, proscar, veterans
VA Study Rates Hytrin Over Proscar
Article | 13 May 1996
- The US Veterans Administration study comparing Abbott's alpha blocker Hytrin (terazosin) and Merck & Co's 5-alpha reductase inhibitor Proscar (finasteride) for ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- New study shows UCB's Neupro reduces NSBP in RLS patient
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
